CEVAC IBIRD LYOPHILISATE FOR SUSPENSION FOR CHICKENS
  • Virus de la bronchite infectieuse aviaire, type 793/B, souche 1/96, Vivant
  • Valid
Export to PDF

Product identification

Medicine name:
CEVAC IBIRD LYOPHILISATE FOR SUSPENSION FOR CHICKENS
Cevac IBird liofilizāts suspensijas pagatavošanai vistām
Active substance and strength:
  • Virus de la bronchite infectieuse aviaire, type 793/B, souche 1/96, Vivant
    2.80
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Authorisation number:
  • V/DCP/13/0031
Product identification number:
  • b5f33794-9c6e-411e-9cb7-7c2101dc935c
Permanent identification number:
  • 600000032287

Product details

Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken (broiler)
      • All relevant tissues
        0
        day
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
  • Oral use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day

Availability

Package description:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • FR/V/0245/001
Date of authorisation status change:
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Authorisation country:
  • Latvia
Responsible authority:
  • Food And Veterinary Service
Marketing authorisation holder:
  • Ceva-Phylaxia Zrt.
Marketing authorisation issued:
Reference member state:
  • France
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

CEVAC IBird_SPC.pdf (PDF)
First published:
Last updated:
CEVAC IBird_PL.pdf (PDF)
First published:
Last updated:
CEVAC IBird_LAB.pdf (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."